Your browser doesn't support javascript.
loading
Peripheral blood CD34+ percentage at hematological recovery after chemotherapy is a good early predictor of harvest: a single-center experience.
Sorasio, Roberto; Bonferroni, Margherita; Grasso, Mariella; Strola, Giuliana; Rapezzi, Davide; Marenchino, Dario; Di Marco, Cristina; Castellino, Claudia; Mattei, Daniele; Mordini, Nicola; Fiore, Francesca; Celeghini, Ivana; Borra, Anna; Ghiglia, Annalisa; Gallamini, Andrea.
Afiliación
  • Sorasio R; Division of Haematology, Santa Croce e Carle Hospital, Cuneo, Italy. Electronic address: sorasio.r@ospedale.cuneo.it.
  • Bonferroni M; Division of Haematology, Santa Croce e Carle Hospital, Cuneo, Italy.
  • Grasso M; Division of Haematology, Santa Croce e Carle Hospital, Cuneo, Italy.
  • Strola G; Laboratory Department, Santa Croce e Carle Hospital, Cuneo, Italy.
  • Rapezzi D; Division of Haematology, Santa Croce e Carle Hospital, Cuneo, Italy.
  • Marenchino D; Immunohematology and Transfusion Medicine, Santa Croce e Carle Hospital, Cuneo, Italy.
  • Di Marco C; Division of Haematology, Santa Croce e Carle Hospital, Cuneo, Italy.
  • Castellino C; Division of Haematology, Santa Croce e Carle Hospital, Cuneo, Italy.
  • Mattei D; Division of Haematology, Santa Croce e Carle Hospital, Cuneo, Italy.
  • Mordini N; Division of Haematology, Santa Croce e Carle Hospital, Cuneo, Italy.
  • Fiore F; Division of Haematology, Santa Croce e Carle Hospital, Cuneo, Italy.
  • Celeghini I; Division of Haematology, Santa Croce e Carle Hospital, Cuneo, Italy.
  • Borra A; Division of Haematology, Santa Croce e Carle Hospital, Cuneo, Italy.
  • Ghiglia A; Division of Haematology, Santa Croce e Carle Hospital, Cuneo, Italy.
  • Gallamini A; Division of Haematology, Santa Croce e Carle Hospital, Cuneo, Italy; Onco-haematology Department, A. Lacassagne Cancer Center, University of Nice, Nice, France.
Biol Blood Marrow Transplant ; 20(5): 717-23, 2014 May.
Article en En | MEDLINE | ID: mdl-24525280

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Enfermedad de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Trasplante de Células Madre de Sangre Periférica / Leucemia-Linfoma Linfoblástico de Células Precursoras / Compuestos Heterocíclicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2014 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Enfermedad de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Trasplante de Células Madre de Sangre Periférica / Leucemia-Linfoma Linfoblástico de Células Precursoras / Compuestos Heterocíclicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2014 Tipo del documento: Article